Pacific Arrow Limited
Records under this name other than patents Pacific Arrow Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,727,561 | Composition Comprising Xanthoceras Sorbifolia Extracts, Compounds Isolated from Same, Methods for Preparing Same and Uses Thereof Term ended Term ended Nov 6, 2023 · High confidence | Term ended | Term ended Nov 6, 2023 | High confidence |
| US 8,735,558 | Blocking the Migration or Metastasis of Cancer Cells by Affecting Adhesion Proteins and the Uses of New Compounds Thereof Term ended Term ended Oct 27, 2023 · High confidence | Term ended | Term ended Oct 27, 2023 | High confidence |
| US 7,262,285 | Anticancer Biangeloyl Saponins Term ended Term ended Nov 27, 2022 · High confidence | Term ended | Term ended Nov 27, 2022 | High confidence |
| US 8,841,265 | Composition Comprising Triterpene Saponins and Compounds with Angeloyl Functional Group, Methods for Preparing Same and Uses Thereof Lapsed on the fee record Ended Sep 23, 2022 · High confidence | Lapsed on the fee record | Ended Sep 23, 2022 | High confidence |
| US 8,586,719 | Novel Triterpenes for Modulating Gene Expression and Cell Membrane, and as Antiprotozoal Agents Term ended Term ended Aug 7, 2022 · High confidence | Term ended | Term ended Aug 7, 2022 | High confidence |
| US 9,382,285 | Methods and Compounds for Modulating the Secretion or Expression of Adhesion Proteins or Angiopoietins of Cells Term ended Ended no later than Jul 30, 2022 · Low confidence | Term ended | Ended no later than Jul 30, 2022 | Low confidence |
| US 8,614,197 | Anti-Tumor Compounds with Angeloyl Groups Lapsed on the fee record Ended Dec 24, 2021 · High confidence | Lapsed on the fee record | Ended Dec 24, 2021 | High confidence |
| US 8,859,012 | Composition Comprising Xanthoceras Sorbifolia Extracts, Compounds Isolated from Same, Methods for Preparing Same and Uses Thereof Term ended Term ended Nov 14, 2021 · High confidence | Term ended | Term ended Nov 14, 2021 | High confidence |
| US 11,485,755 | Natural and Synthetic Compounds for Treating Cancer and Other Diseases Term ended Ended no later than Nov 8, 2021 · Medium confidence | Term ended | Ended no later than Nov 8, 2021 | Medium confidence |
| US 9,434,677 | New Natural and Synthetic Compounds for Treating Cancer and Other Diseases Term ended Ended no later than Oct 11, 2021 · Medium confidence | Term ended | Ended no later than Oct 11, 2021 | Medium confidence |